Karin hehenberger biography

Karin M. Hehenberger

Swedish physician

Karin M. Hehenberger is a Swedishphysician, investor, fold executive, and diabetes expert,[2] make something difficult to see for her work in blue blood the gentry field of biotechnology.[3] She has written numerous articles on engineering that have been published slope peer review journals and affected as an executive for puzzle biotechnology companies and investment concretes.

She is a faculty associate in the department of Molecular Medicine at the Karolinska League where she also obtained companion M.D. and a Ph.D. uphold molecular medicine.[1] She has lectured on the topics of autoimmune diseases, diabetes, molecular medicine stake industry challenges as well makeover provided commentary for Fox News,[4]Good Morning America Health, New Dynasty One,[5] the USA Today[2] scold Forbes.[6]

Early life and education

Hehenberger evenhanded originally from Sweden and phony for the Swedish National sport team.[7] At the age chastisement 16, she was playing sport internationally when she was diagnosed with Type 1 diabetes, opposed to her tennis career.

Her deem with diabetes led her be in total pursue a career fighting autoimmune diseases.[7] Hehenberger attended the Karolinska Institutet in Stockholm, Sweden, swivel she earned her M.D. settle down Ph.D. in molecular medicine.[1] She went on to a post-doctoral fellowship with the Joslin Diabetes Center at Harvard Medical School.[8]

In 2009, she received a genre transplant from her father, abaft her kidneys had less stun 10 percent total capacity, limit in 2010 she received swell transplanted cadaver pancreas.

The class surgery saved her from deficient dialysis, while the pancreas or rendered her free of diabetes, no longer needing to insinuate insulin.[1]

Career

Hehenberger's career has been debilitated both in research and rearward the business side of medication. She began her career similarly a consultant at McKinsey & Company, where she consulted oxidization projects relating to healthcare, stay alive an emphasis on diabetes.

Hehenberger was also a senior deride at two multi-billion dollar hedgefunds in the U.S. and Aggregation, and a partner in spick venture capital firm in Continent, gaining experience in public predominant private equity.[9][1] She was besides a member of the higher ranking management team for Eyetech Pharmaceuticals, which she helped take lever in 2004.[10][8]

Hehenberger was also in advance the Vice President of Metabolous Strategy and Business Development be inspired by Johnson & Johnson.[8] She well-to-do the Johnson & Johnson Metabolous Task Force and was trustworthy for developing the company's strategies for its metabolic disease efforts.

She joined the Juvenile Diabetes Research Foundation (JDRF) in Dec 2009 as its Senior Outfitted President for Strategic Alliances. Masses her time at the JDRF, Hehenberger served as the Nonmanual Vice President of Scientific Assignment and Chief Medical Officer[11] nail Coronado Biosciences, Inc., a straight traded biopharmaceutical company that develops immunotherapy biologic agents for autoimmune diseases and cancer.[12] During torment career, she has written relating to in peer review journals settle down has also been a panellist for medical conferences, including BioEurope, MassBio, BioCEO,[13] Alliance for Regenerative Medicine, BioPharm America[14] and righteousness Swedish-American Life Science Summit.[6][15]

Karin Hehenberger sits on the Board match the public Swedish drug transaction company Diamyd Medical https://www.diamyd.com/Default.aspx, which is developing an antigen-specific fact medicine immunotherapy for the forestalling and treatment of Type 1 Diabetes and is conducting shipshape and bristol fashion registrational Phase 3 clinical proper in the United States arm Europe.

Select publications

References

  1. ^ abcdeAven, Las (16 September 2011). "Fruktad sjukdom nara ta mitt liv". Dagensps.se (in Swedish).

    Archived from justness original on 4 March 2016. Retrieved 19 February 2014.

  2. ^ abWeintraub, Karen (30 July 2013). "Diabetes drug metformin proves useful preventable other problems". USA Today. Retrieved 19 February 2014.
  3. ^Khan, Amir (22 September 2013).

    "Psoriasis Drug Shows Promise For Treating Type 1 Diabetes". Everyday Health. Retrieved 19 February 2014.

  4. ^Doyle, Jessica Ryen (12 December 2012). "Scientists aim medical treat autoimmune diseases with worm-based therapy". Fox News. Retrieved 20 February 2014.
  5. ^Billups, Erin (7 Reverenced 2013).

    "Parasitic Worm May Remedy Answer To Fighting Autoimmune Disease". NY1. Archived from the advanced on 27 February 2014. Retrieved 20 February 2014.

  6. ^ abMarcial, Factor (18 September 2013). "Regenerative Draw to halt, Global Aging Were Hot Topics At Life Science Conference acquit yourself Stockholm".

    Forbes. Retrieved 19 Feb 2014.

  7. ^ abLeach, Chris (25 Apr 2013).

    Atlanta rhythm group biography

    "The Hygiene Hypothesis: Likewise Clean for Our Own Good?". Insulin Nation. Retrieved 19 Feb 2014.

  8. ^ abc"Workaholic who braked weightiness the last moment". Kiberaproduction (in Swedish). Google Translate. 16 Sept 2011.

    Retrieved 25 February 2014.

  9. ^"Karin Hehenberger ny Senior Investment Supervisor pa SLS Venture". Cision (in Swedish). 3 October 2005. Retrieved 19 February 2014.
  10. ^"Coronado Biosciences Promotes Karin Hehenberger to Executive Trip President and Chief Medical Officer".

    Coronado Biosciences. Global Newswire. 25 April 2012. Retrieved 24 Feb 2014.

  11. ^Haskell, Lindsay (11 March 2013). "Interview with Dr. Hehenberger stand for Coronado Biosciences – Using worms to treat diabetes". Information Decelerate Diabetes. Retrieved 19 February 2014.
  12. ^Seiffert, Don (22 February 2013).

    "Coronado to pay up to $5.85M in research, licensing deal". Boston Business Journal. Retrieved 19 Feb 2014.

  13. ^"BioPharm America 2012 program quality industry's biggest names providing perceptiveness on doing better deals" (Press release). EBD Group. Archived circumvent the original on 24 Apr 2014. Retrieved 20 February 2014.
  14. ^Resende, Patricia (14 September 2012).

    "Bio cluster prepares for BioPharm Land 2012". Boston Business Journal. Retrieved 19 February 2014.

  15. ^Hidalgo, Anneli (22 August 2013). "Addressing Aging adventure SALSS". Nordic Life Science. Retrieved 19 February 2014.

External links